Clinical Chemistry, Malmö
1161 – 1170 of 1294
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 1996
-
Mark
Prevalence of factor V gene mutation amongst myocardial infarction patients and healthy controls is higher in Sweden than in other countries
(
- Contribution to journal › Article
-
Mark
Resistance to activated protein C, the FV:Q506 allele, and venous thrombosis
(
- Contribution to journal › Scientific review
-
Mark
High prevalence of the FVR506Q mutation causing APC resistance in a region of southern Sweden with a high incidence of venous thrombosis.
(
- Contribution to journal › Letter
-
Mark
Inherited resistance to activated protein C caused by presence of the FV:Q506 allele as a basis of venous thrombosis
(
- Contribution to journal › Article
-
Mark
Factor V:Q506 mutation and anticardiolipin antibodies in systemic lupus erythematosus
(
- Contribution to journal › Article
-
Mark
The structure of the semenogelin gene locus--nucleotide sequence of the intergenic and the flanking DNA
(
- Contribution to journal › Article
-
Mark
The cloning of a rapidly evolving seminal-vesicle-transcribed gene encoding the major clot-forming protein of mouse semen
(
- Contribution to journal › Article
-
Mark
The gene of the protease inhibitor SKALP/elafin is a member of the REST gene family
(
- Contribution to journal › Article
-
Mark
Distribution and tissue expression of semenogelin I and II in man as demonstrated by in situ hybridization and immunocytochemistry
(
- Contribution to journal › Article
-
Mark
Familial thrombophilia : Resistance to activated protein C and protein S deficiency
1996)(
- Thesis › Doctoral thesis (compilation)